Showing results (131-140 of 587) with videos related to
Sort By:
Pageof 59
The Oncologist|October 23, 2012
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Sarah Barton, Eliza A Hawkes, Andrew Wotherspoon, et al.The Oncologist|June 3, 2011
Targeting angiogenesis in esophagogastric adenocarcinomaAlicia F C Okines, Andrew R Reynolds, David CunninghamTherapeutic Advances in Medical Oncology|December 22, 2018
Immunotherapy and pancreatic cancer: unique challenges and potential opportunitiesKate Young, Daniel J Hughes, David Cunningham, et al.Journal of Geriatric Oncology|September 28, 2013
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapyLisa Lowry, Paul Smith, David Cunningham, et al.Clinical Colorectal Cancer|February 19, 2008
Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive markerDiletta Bianchini, Akali Jayanth, Yu Jo Chua, et al.Drugs|November 24, 2007
Pharmacotherapy for oesophagogastric cancerChristopher Jackson, Naureen Starling, Yu Jo Chua, et al.European Urology|April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literatureFabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.European Urology|March 12, 2013
Medium-term outcomes of active surveillance for localised prostate cancerElizabeth D Selvadurai, Mausam Singhera, Karen Thomas, et al.BJU International|November 8, 2008
Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling timeMichael K Ng, Nicholas Van As, Karen Thomas, et al.Chinese Journal of Cancer|May 7, 2013
Targeting the PI3K-AKT-mTOR signaling network in cancerKhurum H Khan, Timothy A Yap, Li Yan, et al.Pageof 59